USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still’s Disease in Elderly Patients

Background: Patients with solid cancers and hematopoietic malignancy can experience systemic symptoms compatible with adult-onset Still’s disease (AOSD). The newly described VEXAS, associated with somatic UBA1 mutations, exhibits an overlap of clinical and/or biological pictures with auto inflammatory signs and myelodysplastic syndrome (MDS). Objectives: To describe a cohort of patients with signs of undifferentiated systemic autoinflammatory disorder (USAID) concordant with AOSD and MDS/chronic myelomonocytic leukemia (CMML) and the prevalence of VEXAS proposed management and outcome. Methods: A French multicenter retrospective study from the MINHEMON study group also used for other published works with the support of multidisciplinary and complementary networks of physicians and a control group of 104 MDS/CMML. Results: Twenty-six patients were included with a median age at first signs of USAID of 70.5 years with male predominance (4:1). Five patients met the criteria for confirmed AOSD. The most frequent subtypes were MDS with a blast excess (31%) and MDS with multilineage dysplasia (18%). Seven patients presented with acute myeloid leukemia and twelve died during a median follow-up of 2.5 years. Six out of 18 tested patients displayed a somatic UBA1 mutation concordant with VEXAS, including one woman. High-dose corticosteroids led to a response in 13/16 cases and targeted biological therapy alone or in association in 10/12 patients (anakinra, tocilizumab, and infliximab). Azacytidine resulted in complete or partial response in systemic symptoms for 10/12 (83%) patients including 3 VEXAS. Conclusions: Systemic form of VEXAS syndrome can mimic AOSD. The suspicion of USAID or AOSD in older males with atypia should prompt an evaluation of underlying MDS and assessment of somatic UBA1 mutation.

[1]  D. Kastner,et al.  Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. , 2021, Blood advances.

[2]  E. Clappier,et al.  Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease , 2021, Leukemia.

[3]  A. Hoischen,et al.  Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of VEXAS patients. , 2021, The Journal of allergy and clinical immunology.

[4]  C. Haas,et al.  Adult onset Still’s disease in the elderly: a case-based literature review , 2021, BMC Rheumatology.

[5]  D. Kastner,et al.  Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS , 2021, Arthritis & rheumatology.

[6]  J. Maciejewski,et al.  Vacuolization of hematopoietic precursors: an enigma with multiple etiologies , 2021, Blood.

[7]  F. Delhommeau,et al.  VEXAS syndrome: still expanding the clinical phenotype. , 2021, Rheumatology.

[8]  F. Barraco,et al.  Therapeutic options in Vexas syndrome: insights from a retrospective series. , 2021, Blood.

[9]  E. Clappier,et al.  MDS/CMML with TET2 or IDH mutation Are Associated with Systemic Inflammatory and Autoimmune Diseases (SIAD) and T Cell Dysregulation , 2020 .

[10]  J. Mullikin,et al.  Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. , 2020, The New England journal of medicine.

[11]  M. King,et al.  Hiding in Plain Sight - Somatic Mutation in Human Disease. , 2020, The New England journal of medicine.

[12]  M. Buch,et al.  Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease , 2020, RMD Open.

[13]  M. Kawano,et al.  Elderly-onset Still's Disease Complicated by Macrophage Activation Syndrome: A Case Report and Review of the Literature , 2019, Internal medicine.

[14]  M. van Gijn,et al.  Next generation sequencing panel in undifferentiated autoinflammatory diseases identify patients with colchicine-responder recurrent fevers. , 2019, Rheumatology.

[15]  Y. Shoenfeld,et al.  A comprehensive review on adult onset Still's disease. , 2018, Journal of autoimmunity.

[16]  P. Fenaux,et al.  Autoimmune manifestations associated with myelodysplastic syndromes , 2018, Annals of Hematology.

[17]  J. Pouchot,et al.  Validation of the Fautrel classification criteria for adult-onset Still's disease. , 2018, Seminars in arthritis and rheumatism.

[18]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[19]  M. McDermott,et al.  Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology. , 2016, JCI insight.

[20]  D. Solmaz,et al.  Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort. , 2016, Journal of autoimmunity.

[21]  O. Decaux,et al.  Efficacy of Azacitidine in Autoimmune and Inflammatory Disorders associated with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Running title : Azacitidine in autoimmune disorders associated with MDS / CMML , 2018 .

[22]  G. Schett,et al.  Adult onset Still's disease associated with malignancy-Cause or coincidence? , 2016, Seminars in arthritis and rheumatism.

[23]  E. Lee,et al.  Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome , 2016, Medicine.

[24]  J. Piette,et al.  Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. , 2016, Rheumatology.

[25]  R. Ravazzolo,et al.  Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases , 2015, Annals of the rheumatic diseases.

[26]  L. Gensler,et al.  Updates in adult-onset Still disease: Atypical cutaneous manifestations and associations with delayed malignancy. , 2015, Journal of the American Academy of Dermatology.

[27]  S. Scholl,et al.  Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5‐azacytidine and literature review , 2014, European journal of haematology.

[28]  A. Fauchais,et al.  [Adult-onset Still's disease as a manifestation of malignancy: report of a patient with melanoma and literature review]. , 2014, La Revue de medecine interne.

[29]  É. Liozon,et al.  Pseudomaladie de Still et néoplasie : une observation de mélanome et revue de la littérature , 2013 .

[30]  Luca Malcovati,et al.  Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.

[31]  O. Fain,et al.  Manifestations systémiques et auto-immunes des syndromes myélodysplasiques , 2011 .

[32]  P. Fenaux,et al.  [Systemic and autoimmune manifestations in myelodysplastic syndromes]. , 2011, La Revue de medecine interne.

[33]  D. Henrion,et al.  Systemic and immune manifestations in myelodysplasia: A multicenter retrospective study , 2011, Arthritis care & research.

[34]  P. Nguyen,et al.  Myelodysplastic syndromes , 2009, Nature Reviews Disease Primers.

[35]  K. Akashi,et al.  Longstanding Remission of Adult Onset Still’s Disease Under Imatinib Therapy in a Patient with Chronic Myelogenous Leukemia , 2009, The Journal of Rheumatology.

[36]  J. Hayashi,et al.  Chronic myelogenous leukemia that occurred two years after the diagnosis of adult Still's disease. , 2005, Internal medicine.

[37]  K. Matsuo,et al.  A case of adult-onset Still's disease complicated by non-Hodgkin's lymphoma , 2000, Lupus.

[38]  M. Tanigawa,et al.  A case of myelodysplastic syndrome progressing to acute myelocytic leukemia in which adult-onset Still's disease had occurred 6 years before. , 1993, International journal of hematology.

[39]  L. Cavazzini,et al.  Immunoblastic malignant lymphoma in adult onset Still's disease. , 1993, The Journal of rheumatology.

[40]  M. Akizuki,et al.  Preliminary criteria for classification of adult Still's disease. , 1992, The Journal of rheumatology.